What a Medical Exoskeleton and a Robotic Bed Actually Do
A medical robotic exoskeleton is a powered wearable that moves a patient's legs through a walking pattern, either in a clinic for gait rehabilitation or at home for personal mobility. A robotic bed is a hospital or long-term-care bed with powered surface actuation — turning, tilting, or air-cell modulation — intended to reduce pressure injuries and caregiver strain. The FDA classifies powered exoskeletons as class II devices, and beds with active pressure redistribution fall under separate support-surface classifications.
The rehab category is anchored by Ekso Bionics EksoNR for inpatient neurorehabilitation, ReWalk Personal 6.0 for home use in people with spinal cord injury, Cyberdyne HAL Lower Limb, and Wandercraft Atalante X, which walks hands-free. The pressure-relief bed category includes Panasonic Resyone Plus, Hill-Rom / Baxter Progressa, and pressure-relief cushions and overlays from Permobil ROHO.
The Bot Scout view: exoskeletons are bought against a rehabilitation outcome or an independent-mobility outcome, not against a mobility-aid comparison. Robotic beds are bought against a pressure-injury rate and a staffing model, not against a mattress upgrade.
| Product | Category | Clearance / mark | Primary setting | Confirmed vs quote-only pricing |
|---|---|---|---|---|
| Ekso EksoNR | Rehab exoskeleton | FDA cleared for stroke, SCI, ABI, MS (K192469 family) | Inpatient rehab clinic | Quote-only; six-figure capital plus service |
| ReWalk Personal 6.0 | Personal exoskeleton | FDA cleared 2014 (K131798); CE marked | Home use, SCI | Quote-only; historically cited around $85,000+ |
| Cyberdyne HAL Lower Limb | Rehab exoskeleton | FDA de novo 2017 for SCI; CE / Japan PMDA | Rehab clinics | Quote-only; lease model in some markets |
| Wandercraft Atalante X | Rehab exoskeleton | FDA cleared 2022; CE marked | Inpatient rehab clinic | Quote-only; capital purchase |
| Panasonic Resyone Plus | Robotic care bed | ISO 13482 service-robot certified; regional regulatory approvals vary | LTC / home care (Japan-led) | Quote-only in export markets |
| Hill-Rom / Baxter Progressa | ICU therapy bed | FDA-listed class II hospital bed | ICU / acute care | Quote-only; typically leased with service |
| ROHO pressure-relief cushions | Pressure-relief surface | FDA-listed class II support surface | Wheelchair / bed overlay | Public list pricing on many resellers |
How FDA and CE Status Actually Read on the Spec Sheet
Regulatory status decides who can prescribe the device, in what setting, and for which indication. ReWalk Personal 6.0 (K131798) was the first personal exoskeleton cleared by the FDA for home use in people with spinal cord injury at specific lesion levels. Cyberdyne HAL received a de novo classification (DEN160055) in 2017 for chronic spinal cord injury.
Wandercraft Atalante X is FDA-cleared for gait training in adults with hemiplegia after stroke, and CE-marked for broader rehab use — the hands-free design is the differentiator against crutch-based exoskeletons. Ekso Bionics has expanded EksoNR clearances across stroke, spinal cord injury, acquired brain injury, and multiple sclerosis; the exact intended-use language matters when a payer reviews a claim.
For beds, ISO 13482:2014 covers personal-care robot safety and is the standard Panasonic cites for Resyone as the first certified robotic care bed under that standard. Hospital beds like Progressa are regulated as class II medical devices; pressure-redistribution surfaces are separately listed. A "robotic bed" label in a brochure is not the same as an active-therapy indication in a payer policy.
- Ask for the exact FDA product code and clearance number — not just "FDA cleared".
- Confirm the indications for use match the patient population you actually treat.
- For CE marking, confirm the notified body, class, and any national-registry requirement.
- For beds, separate the bed clearance from the surface / mattress clearance — they are distinct devices.
- Ask which components require recertification after service, and who is authorized to perform it.
What Insurance Actually Covers Today
Personal exoskeletons crossed a coverage threshold in 2024. CMS finalized HCPCS code K1007 for personal-use powered lower-extremity exoskeletons and, per MLN Matters MM13385, established payment under the DME benefit at a level widely reported around $91,000 for the device. ReWalk (now Lifeward) publicly tracked Medicare coverage of personal exoskeletons as a company milestone.
For clinic-based exoskeletons (EksoNR, HAL, Atalante) coverage runs through the rehabilitation facility's bundled payment rather than a device-specific code — the hospital or IRF absorbs the capital and bills the therapy. That is why the same exoskeleton can be routine at a large rehab hospital and unavailable in a small clinic across the street.
Robotic and therapy beds are typically covered through inpatient DRG payments in acute care, not as a separately billed item. In long-term care and home settings, pressure-relief surfaces are covered under HCPCS support-surface groups 1–3 depending on documented risk and existing pressure injuries — a robotic bed marketed for prevention will not automatically qualify without the underlying clinical justification.
| Device type | US coverage path | Where it usually breaks down |
|---|---|---|
| Personal exoskeleton (home use, SCI) | Medicare DME under HCPCS K1007; commercial payers follow with medical-necessity criteria | Prior authorization, home-safety assessment, and training completion |
| Clinic rehab exoskeleton | Bundled into IRF / SNF / outpatient therapy payment; no device-specific code | Facility justifies capital against therapy volume and outcomes |
| ICU therapy bed | Inpatient DRG; may be a rental line inside the facility | Fleet utilization and service contract, not per-patient billing |
| Pressure-relief surface (LTC / home) | HCPCS group 1 / 2 / 3 surfaces per Medicare LCDs | Documentation of stage of injury and prior interventions |
Cost Signals Buyers Can Actually Verify
Public list pricing is rare in this category. The most-cited confirmed data point is the CMS payment level for HCPCS K1007, which sets a Medicare benchmark for personal exoskeletons; the K1007 payment article is the authoritative reference. Clinic-grade exoskeleton pricing is quote-only and depends on service term, training package, and analytics subscription.
For beds, ROHO cushions and overlays from Permobil have street pricing available through DME resellers, but ICU therapy beds like Progressa are generally leased with service and rarely quoted publicly. Panasonic Resyone availability outside Japan is limited and priced through regional distributors.
The honest budget line most buyers underestimate is service and training. A rehab exoskeleton without a trained therapist team is expensive furniture; a therapy bed without a preventive-maintenance contract turns into a rental line item when actuators fail.
How to Match a Device to a Setting
Inpatient rehabilitation hospitals with stroke, SCI, and brain-injury volume are the natural buyers of EksoNR, HAL, and Atalante. Outpatient neuro clinics without inpatient volume struggle to justify the capital unless the exoskeleton anchors a specialty program.
Personal use is a narrow indication — ReWalk Personal 6.0 targets people with spinal cord injury who meet specific lesion, height, and weight criteria and complete a training program. It is not a substitute for a wheelchair and does not replace the need for one.
For beds, ICUs with high-acuity turning and mobilization needs justify a Progressa-class therapy bed. Skilled nursing and home settings usually solve the same problem with a group-2 or group-3 pressure-relief surface plus a documented turning schedule — a full robotic bed is rarely the first purchase.
- Map the device to a specific patient population and a measurable outcome before the vendor visit.
- Confirm the reimbursement path in writing with your billing team, not just the vendor's marketing.
- Budget clinician training as an operating expense every year, not a one-time setup.
- Ask for reference sites at your patient volume, not the vendor's flagship account.
- For beds, quote the surface separately from the frame — they are separate purchases and separate replacements.
Bottom Line
Rehab exoskeletons and pressure-relief robotic beds are legitimate medical devices with real evidence bases, but they are bought against clinical outcomes and reimbursement paths — not against consumer specs. Confirm the FDA or CE clearance language, confirm the payer path in writing, and budget service and training as ongoing costs.
Before requesting a quote, write down the patient population, the outcome you will measure, and the exact reimbursement code that will pay for it.
FAQs
Is a medical exoskeleton covered by Medicare?
Personal-use lower-extremity exoskeletons for people with spinal cord injury are covered under HCPCS code K1007 as durable medical equipment, following CMS's 2024 coding and payment decision. Clinic-based exoskeletons are paid through the rehabilitation facility's bundled payment rather than a device-specific code.
How much does a rehab exoskeleton cost?
Clinic-grade devices like EksoNR, Cyberdyne HAL, and Wandercraft Atalante are quote-only capital purchases typically in the six-figure range plus annual service and training. ReWalk Personal 6.0 has historically been cited around $85,000, and CMS payment under K1007 has been reported around $91,000.
Does a robotic bed prevent pressure sores?
Powered pressure-redistribution surfaces reduce risk when combined with a documented repositioning protocol and appropriate risk assessment. A robotic bed alone does not replace turning schedules, skin assessment, and nutrition management, and payers require that underlying clinical documentation.
Can I use a ReWalk or Ekso exoskeleton at home?
Only devices cleared by the FDA for personal use, such as ReWalk Personal 6.0, are intended for at-home use, and only for indicated patient populations after a training program. Clinic devices like EksoNR are cleared for supervised use in a rehabilitation setting.
What is the difference between a hospital bed and a robotic bed?
A standard hospital bed offers powered height, head, and knee adjustment. A robotic bed adds active surface actuation — automated turning, tilt, or air-cell modulation — and, in the case of Panasonic Resyone, transforms between a bed and a wheelchair. The robotic category is regulated separately and is not a simple upgrade path.